Evidence map›Paper›PMID 37794457›Full record

ArticleBioelectronic medicine2023

The Fifth Bioelectronic Medicine Summit: today's tools, tomorrow's therapies.

Eric H Chang, Arielle H Gabalski, Tomas S Huerta, Timir Datta-Chaudhuri, Theodoros P Zanos, Stavros Zanos, Warren M Grill, Kevin J Tracey, Yousef Al-Abed

Open access · goldAbstract read
In one paragraph

Article in Bioelectronic medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Eric H ChangFeinstein Institutes for Medical Research, Northwell Health, 350 Community Drive, Manhasset, NY, 11030, USA. echang1@northwell.edu.ORCID http://orcid.org/0000-0001-5592-4276
Arielle H GabalskiFeinstein Institutes for Medical Research, Northwell Health, 350 Community Drive, Manhasset, NY, 11030, USA.
Tomas S HuertaFeinstein Institutes for Medical Research, Northwell Health, 350 Community Drive, Manhasset, NY, 11030, USA.
Timir Datta-ChaudhuriFeinstein Institutes for Medical Research, Northwell Health, 350 Community Drive, Manhasset, NY, 11030, USA.ORCID http://orcid.org/0000-0001-7377-1939
Theodoros P ZanosFeinstein Institutes for Medical Research, Northwell Health, 350 Community Drive, Manhasset, NY, 11030, USA.ORCID http://orcid.org/0000-0002-9204-9551
Stavros ZanosFeinstein Institutes for Medical Research, Northwell Health, 350 Community Drive, Manhasset, NY, 11030, USA.ORCID http://orcid.org/0000-0002-3967-8164
Warren M GrillDepartment of Biomedical Engineering, Fitzpatrick CIEMAS, Duke University, Room 1427, 101 Science Drive, Box 90281, Durham, NC, 27708, USA.
Kevin J TraceyFeinstein Institutes for Medical Research, Northwell Health, 350 Community Drive, Manhasset, NY, 11030, USA.ORCID http://orcid.org/0000-0003-1884-6314
Yousef Al-AbedFeinstein Institutes for Medical Research, Northwell Health, 350 Community Drive, Manhasset, NY, 11030, USA.
Northwell Health · USDuke University · US

Funding

T32 Training Grant in Translational ImmunologyT32AI155392 · NIAID · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI Anne Davidson · 2021 to 2026
$1.6M
Encoding of inflammatory mediators by vagal sensory neuronsR01GM143362 · NIGMS · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI CHANG, ERIC HAU-YUN · 2021 to 2024
$1.6M
NIAID NIH HHS T32 AI155392NIGMS NIH HHS R01 GM143362
6 · The paper itself

Abstract

The emerging field of bioelectronic medicine (BEM) is poised to make a significant impact on the treatment of several neurological and inflammatory disorders. With several BEM therapies being recently approved for clinical use and others in late-phase clinical trials, the 2022 BEM summit was a timely scientific meeting convening a wide range of experts to discuss the latest developments in the field. The BEM Summit was held over two days in New York with more than thirty-five invited speakers and panelists comprised of researchers and experts from both academia and industry. The goal of the meeting was to bring international leaders together to discuss advances and cultivate collaborations in this emerging field that incorporates aspects of neuroscience, physiology, molecular medicine, engineering, and technology. This Meeting Report recaps the latest findings discussed at the Meeting and summarizes the main developments in this rapidly advancing interdisciplinary field. Our hope is that this Meeting Report will encourage researchers from academia and industry to push the field forward and generate new multidisciplinary collaborations that will form the basis of new discoveries that we can discuss at the next BEM Summit.

Indexed as

Materials scienceNeuroimmunologyNeuromodulationNeurotechnologyPreclinical research

Identifiers

PMID37794457
PMCPMC10552422
OpenAlexW4387345253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.